Dose-Response Relationship, DrugDrug Administration ScheduleDouble-Blind MethodRadiation DosageAdministration, OralTreatment OutcomeTime FactorsImmunization ScheduleDrug Therapy, CombinationImmunization, SecondaryMeasles VaccineRotavirus VaccinesArea Under CurveHalf-LifeInfusions, IntravenousIntussusceptionMeaslesVaccinationMeasles-Mumps-Rubella VaccineAntineoplastic Combined Chemotherapy ProtocolsInjections, IntravenousHepatitis B VaccinesDrug CombinationsVaccines, CombinedPlacebosAnti-Bacterial AgentsProspective StudiesImmunization ProgramsInfant, NewbornAntineoplastic AgentsInjections, IntramuscularDrug EvaluationDrug InteractionsVaccines, AttenuatedDiphtheria-Tetanus-Pertussis VaccineNeoplasmsDrug ToleranceAntibodies, ViralRetrospective StudiesVomitingNauseaFollow-Up StudiesImmunosuppressive AgentsMumpsBlood PressureGentamicinsNetilmicinCyclophosphamidePregnancyInfluenza VaccinesRotavirus InfectionsInjections, SubcutaneousAntibodies, MonoclonalMisoprostolAntimalarialsClinical Trials as TopicNeutropeniaLethal Dose 50Poliovirus Vaccine, InactivatedHeart RateCross-Over StudiesMetabolic Clearance RateHemagglutination Inhibition TestsChromatography, High Pressure LiquidAlbuterolAntibodies, Monoclonal, HumanizedFeverAnti-Infective AgentsDiphtheria-Tetanus-acellular Pertussis VaccinesRats, Sprague-DawleyAntibiotic ProphylaxisHepatitis A VaccinesAdministration, InhalationCombined Modality TherapyPoliovirus Vaccine, OralSingle-Blind MethodAcute DiseaseQuinolinesChickenpox VaccineMorphineAnalgesics, OpioidAnalysis of VarianceArtemisininsDoxorubicinSafetyDexamethasoneVincristineHypotensionFluorouracilTetanus ToxoidCisplatinCohort StudiesImmunoglobulin GRecombinant ProteinsCephalosporinsAge FactorsMass VaccinationBody WeightBronchodilator AgentsSurvival Analysis